Adapting to Change: API Custom Development and Manufacturing

Case study
Drug substance

Cambrex was approached by a top 100 European-based pharmaceutical company looking for a development and manufacturing partner to assist with an in-licensed product originating from an emerging pharma company. The molecule was in clinical Phase II / III trials and the customer required development work and scale-up to commercial manufacturing. The chemistry required was particularly challenging, and Cambrex needed to upgrade its commercial manufacturing assets prior to project initiation within 4 months. Cambrex was selected to assist with the project as we had an existing relationship with the originator company, extensive experience with the chemistry and process, and the necessary scale-up and commercial production expertise.

Read the full case study to learn how Cambrex was able to meet the client’s aggressive timeline and flexibility requirements.

Be the first to receive our latest news and updates